[1]孔雪晴,沙咏怡,项敏泓.氧化应激及天然食物中的抗氧化剂在干眼中的作用研究进展[J].眼科新进展,2024,44(3):235-238.[doi:10.13389/j.cnki.rao.2024.0046]
　KONG Xueqing,SHA Yongyi,XIANG Minhong.Research progress on oxidative stress and effects of antioxidants from natural foods on dry eyes[J].Recent Advances in Ophthalmology,2024,44(3):235-238.[doi:10.13389/j.cnki.rao.2024.0046]
点击复制

氧化应激及天然食物中的抗氧化剂在干眼中的作用研究进展/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
44卷
期数:
2024年3期
页码:
235-238
栏目:
文献综述
出版日期:
2024-03-05

文章信息/Info

Title:
Research progress on oxidative stress and effects of antioxidants from natural foods on dry eyes
作者:
孔雪晴; 沙咏怡; 项敏泓
200062　上海市，上海中医药大学附属普陀医院眼科
Author(s):
KONG Xueqing; SHA Yongyi; XIANG Minhong
Department of Ophthalmology，Putuo Hospital，Shanghai University of Traditional Chinese Medicine,Shanghai 200062,China
关键词:
氧化应激; 干眼; 抗氧化剂; 天然食物
Keywords:
oxidative stress;  dry eye;  antioxidant;  natural foods
分类号:
R777.34
DOI:
10.13389/j.cnki.rao.2024.0046
文献标志码:
A
摘要:
干眼是以泪膜不稳定、眼部不适为特征的年龄相关性疾病，其发病与年龄、环境等多种因素密切相关。研究表明，氧化应激在干眼的发病过程中起关键作用。本文主要就氧化应激通过激活自噬、炎症和衰老等诱导干眼发生的机制以及天然食物中抗氧化剂对于改善眼表氧化应激状态、治疗干眼方面的应用进展进行综述。
Abstract:
Dry eye is an age-related disease characterized by tear film instability and ocular discomfort. Its onset is closely related to various factors such as age and environment. Studies have shown that oxidative stress plays a key role in the pathogenesis of dry eyes. This review mainly describes the mechanism of oxidative stress by activating autophagy, inflammation and aging to induce dry eyes, and the application progress of the antioxidants from natural foods in relieving the oxidative stress state of the ocular surface and treating dry eyes.

参考文献/References:

［1］　TSUBOTA K,PFLUGFELDER S C,LIU Z G,BAUDOUIN C,KIM H M,MESSMER E M,et al.Defining dry eye from a clinical perspective［J］.Int J Mol Sci,2020,21(23):9271.
［2］　STAPLETON F,ALVES M,BUNYA V Y,JALBERT I,LEKHANONT K,MALET F,et al.TFOS DEWS II epidemiology report［J］.Ocul Surf,2017,15(3):334-365.
［3］　刘祖国,王华.关注干眼慢性疾病管理体系的建设［J］.中华眼科杂志,2018,54(2):81-83.
LIU Z G,WANG H.Focusing on the management of chronic dry eye disease［J］.Chin J Ophthalmol,2018,54(2):81-83.
［4］　ROUEN P A,WHITE M L.Dry eye disease［J］.Home Healthc Now,2018,36(2):74-83.
［5］　PFLUGFELDER S C.Prevalence,burden,and pharmacoeconomics of dry eye disease［J］.Am J Manag Care,2008,14(3 Suppl):S102-S106.
［6］　SEEN S,TONG L.Dry eye disease and oxidative stress［J］.Acta Ophthalmol,2018,96(4):e412-e420.
［7］　GALLUZZI L,BAEHRECKE E H,BALLABIO A,BOYA P,BRAVO-SAN PEDRO J M,CECCONI F,et al.Molecular definitions of autophagy and related processes［J］.EMBO J,2017,36(13):1811-1836.
［8］　YANG X,PAN X N,ZHAO X R,LUO J,XU M P,BAI D M,et al.Autophagy and age-related eye diseases［J］.BioMed Res Int,2019,2019:5763658.
［9］　ZHANG L,WANG H D,XU J G,ZHU J H,DING K.Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways［J］.Toxicol Lett,2014,228(3):248-259.
［10］　VAN ERP A C,HOEKSMA D,REBOLLEDO R A,OTTENS P J,JOCHMANS I,MONBALIU D,et al.The crosstalk between ROS and autophagy in the field of transplantation medicine［J］.Oxid Med Cell Longev,2017,2017:7120962.
［11］　LI X H,HE S K,MA B Y.Autophagy and autophagy-related proteins in cancer［J］.Mol Cancer,2020,19(1):12.
［12］　PE?A-MARTINEZ C,RICKMAN A D,HECKMANN B L.Beyond autophagy:LC3-associated phagocytosis and endocytosis［J］.Sci Adv,2022,8(43):eabn1702.
［13］　YIN Y Y,ZONG R R,BAO X R,ZHENG X L,CUI H X,LIU Z G,et al.Oxidative stress suppresses cellular autophagy in corneal epithelium［J］.Invest Ophthalmol Vis Sci,2018,59(8):3286-3293.
［14］　AHMAD A,AHSAN H.Biomarkers of inflammation and oxidative stress in ophthalmic disorders［J］.J Immunoass Immunochem,2020,41(3):257-271.
［15］　DAMMAK A,PASTRANA C,MARTIN-GIL A,CARPENA-TORRES C,PERAL CERDA A,SIMOVART M,et al.Oxidative stress in the anterior ocular diseases:diagnostic and treatment［J］.Biomedicines,2023,11(2):292.
［16］　KOJIMA T,WAKAMATSU T H,DOGRU M,OGAWA Y,IGARASHI A,IBRAHIM O M,et al.Age-related dysfunction of the lacrimal gland and oxidative stress:evidence from the Cu,Zn-superoxide dismutase-1 (Sod1) knockout mice［J］.Am J Pathol,2012,180(5):1879-1896.
［17］　WAKAMATSU T H,DOGRU M,MATSUMOTO Y,KOJIMA T,KAIDO M,IBRAHIM O M,et al.Evaluation of lipid oxidative stress status in Sj?gren syndrome patients［J］.Invest Ophthalmol Vis Sci,2013,54(1):201-210.
［18］　MA K,LIU J,SHA Y,ZHANG W,NI Z,KONG X,et al.Qi Jing Mingmu Decoction inhibits the p38 signaling pathway in conjunctivochalasis fibroblasts by down-regulation of Th17 cell differentiation［J］.J Ethnopharmacol,2023,301:115812.
［19］　WARD S K,WAKAMATSU T H,DOGRU M,IBRAHIM O M,KAIDO M,OGAWA Y,et al.The role of oxidative stress and inflammation in conjunctivochalasis［J］.Invest Ophthalmol Vis Sci,2010,51(4):1994-2002.
［20］　COHEN A A.Complex systems dynamics in aging:new evidence,continuing questions［J］.Biogerontology,2016,17(1):205-220.
［21］　DE PAIVA C S.Effects of aging in dry eye［J］.Int Ophthalmol Clin,2017,57(2):47-64.
［22］　DOGRU M,KOJIMA T,SIMSEK C,TSUBOTA K.Potential role of oxidative stress in ocular surface inflammation and dry eye disease［J］.Invest Ophthalmol Vis Sci,2018,59(14):DES163-DES168.
［23］　BARABINO S.Is dry eye disease the same in young and old patients? A narrative review of the literature［J］.BMC Ophthalmol,2022,22:85.
［24］　KOJIMA T,DOGRU M,IBRAHIM O M,WAKAMATSU T H,ITO M,IGARASHI A,et al.Effects of oxidative stress on the conjunctiva in Cu,Zn-superoxide dismutase-1 (Sod1)-knockout mice［J］.Invest Ophthalmol Vis Sci,2015,56(13):8382-8391.
［25］　XIANG M H,MO L J,ZHAN Y P,WEN H,ZHOU H M,MIAO W H.P38-mediated cellular senescence in conjunctivochalasis fibroblasts［J］.Invest Ophthalmol Vis Sci,2019,60(14):4643-4651.
［26］　CEJKA C,KUBINOVA S,CEJKOVA J.Trehalose in ophthalmology［J］.Histol Histopathol,2019,34(6):611-618.
［27］　LAIHIA J,KAARNIRANTA K.Trehalose for ocular surface health［J］.Biomolecules,2020,10(5):809.
［28］　STROM J,XU B,TIAN X,CHEN Q M.Nrf2 protects mitochondrial decay by oxidative stress［J］.FASEB J,2016,30(1):66-80.
［29］　MIZUNOE Y,KOBAYASHI M,SUDO Y,WATANABE S,YASUKAWA H,NATORI D,et al.Trehalose protects against oxidative stress by regulating the Keap1-Nrf2 and autophagy pathways［J］.Redox Biol,2018,15:115-124.
［30］　HILL-BATOR A,MISIUK-HOJO M,MARYCZ K,GRZESIAK J.Trehalose-based eye drops preserve viability and functionality of cultured human corneal epithelial cells during desiccation［J］.Biomed Res Int,2014,2014:292139.
［31］　BRAR S,VANGA H R,GANESH S.Comparison of efficacy of trehalose-based eye drops versus topical 0.1% Hyaluronic Acid for management of clinically significant dry eye using non-invasive investigational modalities［J］.Int Ophthalmol,2021,41(10):3349-3359.
［32］　SALEHI B,BERKAY YILMAZ Y,ANTIKA G,BOYUNEGMEZ TUMER T,FAWZI MAHOMOODALLY M,LOBINE D,et al.Insights on the use of α-lipoic acid for therapeutic purposes［J］.Biomolecules,2019,9(8):356.
［33］　AJITH T A.Alpha-lipoic acid:a possible pharmacological agent for treating dry eye disease and retinopathy in diabetes［J］.Clin Exp Pharmacol Physiol,2020,47(12):1883-1890.
［34］　ROSZKOWSKA A M,SPINELLA R,OLIVERIO G W,POSTORINO E I,SIGNORINO G A,RUSCIANO D,et al.Effects of the topical use of the natural antioxidant alpha-lipoic acid on the ocular surface of diabetic patients with dry eye symptoms［J］.Front Biosci (Landmark Ed),2022,27(7):202.
［35］　CHAGAS M D S S,BEHRENS M D,MORAGAS-TELLIS C J,PENEDO G X M,SILVA A R,GONALVES-DE-ALBUQUERQUE C F.Flavonols and flavones as potential anti-inflammatory,antioxidant,and antibacterial compounds［J］.Oxid Med Cell Longev,2022,2022:9966750.
［36］　RAUF A,IMRAN M,KHAN I A,UR-REHMAN M,GILANI S A,MEHMOOD Z,et al.Anticancer potential of quercetin:a comprehensive review［J］.Phytother Res,2018,32(11):2109-2130.
［37］　王亚茹,袁满,张丽,张樱樱,廖鹏,姚站馨.槲皮素抗氧化作用及相关机制研究进展［J］.营养学报,2022,44(2):204-208.
WANG Y R,YUAN M,ZHANG L,ZHANG Y Y,LIAO P,YAO Z X.Research progress on antioxidant actions and related mechanisms of quercetin［J］.Acta Nutr Sin,2022,44(2):204-208.
［38］　MCKAY T B,KARAMICHOS D.Quercetin and the ocular surface:what we know and where we are going［J］.Exp Biol Med,2017,242(6):565-572.
［39］　OH H N,KIM C E,LEE J H,YANG J W.Effects of quercetin in a mouse model of experimental dry eye［J］.Cornea,2015,34(9):1130-1136.
［40］　KIM S H,KIM H.Inhibitory effect of astaxanthin on oxidative stress-induced mitochondrial dysfunction-a mini-review［J］.Nutrients,2018,10(9):1137.
［41］　FAKHRI S,ABBASZADEH F,DARGAHI L,JORJANI M.Astaxanthin:a mechanistic review on its biological activities and health benefits［J］.Pharmacol Res,2018,136:1-20.
［42］　CAI X,HUA S,DENG J,DU Z,ZHANG D,LIU Z,et al.Astaxanthin activated the Nrf2/HO-1 pathway to enhance autophagy and inhibit ferroptosis,ameliorating acetaminophen-induced liver injury［J］.ACS Appl Mater Interfaces,2022,14(38):42887-42903.
［43］　KIM S H,KIM H.Astaxanthin modulation of signaling pathways that regulate autophagy［J］.Mar Drugs,2019,17(10):546.
［44］　HUANG J Y,YEH P T,HOU Y C.A randomized,double-blind,placebo-controlled study of oral antioxidant supplement therapy in patients with dry eye syndrome［J］.Clin Ophthalmol,2016,10:813-820.
［45］　GIANNACCARE G,PELLEGRINI M,SENNI C,BERNABEI F,SCORCIA V,CICERO A F G.Clinical applications of astaxanthin in the treatment of ocular diseases:emerging insights［J］.Mar Drugs,2020,18(5):239.
［46］　TSAI H Y,HO C T,CHEN Y K.Biological actions and molecular effects of resveratrol,pterostilbene,and 3’-hydroxypterostilbene［J］.J Food Drug Anal,2017,25(1):134-147.
［47］　LANGE K W,LI S.Resveratrol,pterostilbene,and dementia［J］.BioFactors,2018,44(1):83-90.
［48］　黄梨,龙佑梅,夏良斌.紫檀芪在恶性肿瘤中的抗癌机制研究进展［J］.实用医学杂志,2019,35(20):3253-3257.
HUANG L,LONG Y M,XIA L B.Research progress on anti-cancer mechanism of pterostilbene in malignant tumors［J］.J Pract Med,2019,35(20):3253-3257.
［49］　郭野,陈美霓,李家萱.白藜芦醇的临床应用研究进展［J］.新乡医学院学报,2023,40(3):290-294.
GUO Y,CHEN M N,LI J X.Research progress in clinical application of resveratrol［J］.J Xinxiang Med Univ,2023,40(3):290-294.
［50］　ARINNO A,APAIJAI N,CHATTIPAKORN S C,CHATTIPAKORN N.The roles of resveratrol on cardiac mitochondrial function in cardiac diseases［J］.Eur J Nutr,2021,60(1):29-44.
［51］　CHEN C,ZHOU M,GE Y C,WANG X B.SIRT1 and aging related signaling pathways［J］.Mech Ageing Dev,2020,187:111215.
［52］　CHEN J X,ZHANG W J,ZHENG Y X,XU Y Z.Ameliorative potential of resveratrol in dry eye disease by restoring mitochondrial function［J］.Evid Based Complementary Altern Med,2022,2022:1-10.
［53］　LI J,DENG R Z,HUA X,ZHANG L L,LU F,TERRY G,et al.Blueberry component pterostilbene protects corneal epithelial cells from inflammation via anti-oxidative pathway［J］.Sci Rep,2016,6:19408.

相似文献/References:

[1]陈放 徐珊 吕伟红 程宏 张洪泉.糖尿病大鼠视网膜的氧化应激损伤及葛根素对其的干预作用[J].眼科新进展,2012,32(1):000.
[2]解正高 陈放 庄朝荣 王健 朱俊 季河清 王雅坤.银杏叶提取物增强大鼠视网膜光损伤模型抗氧化应激能力[J].眼科新进展,2012,32(1):000.
[3]杨鑫 张凤妍 方梦园 张金嵩 彭广华.PUMA 介导氧化应激诱导的人晶状体上皮细胞凋亡[J].眼科新进展,2012,32(5):000.
[4]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[5]姜洋 李莹 王忠海 罗岩 金玉梅.小牛血去蛋白提取物眼用凝胶对LASIK 术后角膜修复及干眼的疗效观察[J].眼科新进展,2012,32(7):000.
[6]叶芬 王春红 陈银 施宇华 黄振平.人工泪液对糖尿病干眼患者泪河的影响[J].眼科新进展,2012,32(12):000.
[7]张磊 何彦津.无眼征Graves病患者的眼表损害[J].眼科新进展,2012,32(12):000.
[8]喻小龙 谭钢 刘二华 周寿红.罗格列酮对高糖诱导视网膜神经节细胞损伤的保护作用[J].眼科新进展,2013,33(2):000.
[9]王观峰 李文立 邹秀兰 邹玉平 皮荣标 姚敏.硫辛酸烟酸二联体对丙烯醛损伤ARPE-19细胞的保护作用[J].眼科新进展,2013,33(2):000.
[10]皮百木 穆红梅 张婉婷 郑娜 李娟.老年干眼患者眼表改变及其与睑板腺功能障碍的相关性[J].眼科新进展,2013,33(6):000.
[11]徐晓玮,朱佩文,邵毅.氧化应激因素在干眼中的临床研究[J].眼科新进展,2019,39(1):086.[doi:10.13389/j.cnki.rao.2019.0020]
　XU Xiao-Wei,ZHU Pei-Wen,SHAO Yi.Oxidative stress in dry eye[J].Recent Advances in Ophthalmology,2019,39(3):086.[doi:10.13389/j.cnki.rao.2019.0020]

备注/Memo

备注/Memo:
国家自然科学基金资助（编号：82074495）；上海市普陀区中心医院匠才计划（编号：2022-RCJC-06）
更新日期/Last Update: 2024-03-05